# Fidelity Wise Origin Bitcoin Fund: financial statements, quarterly

FBTC · CBOE · CIK 1852317 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fbtc.md) · [Financials](/companies/fbtc/financials.md) · [Filings](/companies/fbtc/filings.md) · [Insiders](/companies/fbtc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fbtc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [2,628](/filings/0000950170-25-067926.md) | [(1,201)](/filings/0000950170-25-105585.md) | [41.0](/filings/0001193125-25-271721.md) | [5,475 d](/filings/0001193125-26-071484.md) | [(2,240)](/filings/0001193125-26-208428.md) | [4,758](/filings/0001193125-26-337679.md) | [1,372](/filings/0001193125-25-271721.md) | [(5,476) d](/filings/0001193125-26-071484.md) | [(3,738)](/filings/0001193125-26-208428.md) | [(1,608)](/filings/0001193125-26-337679.md) |

- Net income: us-gaap:ProfitLoss

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0000950170-25-039452.md) | [0.0](/filings/0000950170-24-056545.md) | [0.0](/filings/0000950170-24-094562.md) | [0.0](/filings/0000950170-24-126256.md) | [0.0](/filings/0000950170-25-039452.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [0.0](/filings/0000950170-25-039452.md) | [10.3](/filings/0000950170-24-056545.md) | [10.6](/filings/0000950170-24-094562.md) | [11.5](/filings/0000950170-24-126256.md) | [18.9](/filings/0001193125-26-071484.md) | [16.3](/filings/0000950170-25-067926.md) | [21.6](/filings/0000950170-25-105585.md) | [23.3](/filings/0001193125-25-271721.md) | [17.7](/filings/0001193125-26-337679.md) | [12.8](/filings/0001193125-26-208428.md) | [10.3](/filings/0001193125-26-337679.md) |
| Total liabilities | $bn | [0.0](/filings/0000950170-25-039452.md) | [0.1](/filings/0000950170-24-056545.md) | [0.0](/filings/0000950170-24-094562.md) | [0.0](/filings/0000950170-24-126256.md) | [0.0](/filings/0001193125-26-071484.md) | [0.0](/filings/0000950170-25-067926.md) | [0.0](/filings/0000950170-25-105585.md) | [0.1](/filings/0001193125-25-271721.md) | [0.1](/filings/0001193125-26-337679.md) | [0.0](/filings/0001193125-26-208428.md) | [0.0](/filings/0001193125-26-337679.md) |
| Shareholders' equity | $bn | [0.0](/filings/0000950170-25-039452.md) | [10.2](/filings/0000950170-24-056545.md) | [10.6](/filings/0000950170-24-094562.md) | [11.5](/filings/0000950170-24-126256.md) | [18.8](/filings/0001193125-26-337679.md) | [16.3](/filings/0001193125-26-337679.md) | [21.6](/filings/0001193125-26-337679.md) | [23.3](/filings/0001193125-25-271721.md) | [17.6](/filings/0001193125-26-337679.md) | [12.8](/filings/0001193125-26-337679.md) | [10.3](/filings/0001193125-26-337679.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(7,519)](/filings/0000950170-25-067926.md) | [(1,692) d](/filings/0000950170-25-105585.md) | [(794) d](/filings/0001193125-25-271721.md) | [(1,700) d](/filings/0001193125-26-071484.md) | [204](/filings/0001193125-26-208428.md) | [(493) d](/filings/0001193125-26-337679.md) | [(257) d](/filings/0001193125-25-271721.md) | [418 d](/filings/0001193125-26-071484.md) | [1,248](/filings/0001193125-26-208428.md) | [414 d](/filings/0001193125-26-337679.md) |
| Share repurchases | $m | [1.5](/filings/0000950170-25-067926.md) | [763 d](/filings/0000950170-25-105585.md) | [880 d](/filings/0001193125-25-271721.md) | [2,188 d](/filings/0001193125-26-071484.md) | [2,905](/filings/0001193125-26-208428.md) | [1,893 d](/filings/0001193125-26-337679.md) | [2,526 d](/filings/0001193125-25-271721.md) | [2,471 d](/filings/0001193125-26-071484.md) | [2,649](/filings/0001193125-26-208428.md) | [1,429 d](/filings/0001193125-26-337679.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 197,403,476 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337679.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.